• Skip to main content
  • Skip to secondary menu
  • Skip to footer

ESN.net, event sharing network

Electronic Syndicated News

  • Share Your Event
  • Events
  • Markets
  • About
  • Contact

2022 BIO CEO & Investor Conference, February 14-17, 2022

February 9, 2022 By ESN.net Leave a Comment

Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference

ROCKVILLE, Md., Feb. 9, 2022 – Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that the Company will be presenting at the 2022 BIO CEO & Investor Conference being held February 14-17, 2022. The conference will be conducted as a hybrid event at the New York Marriott Marquis and virtually.

Steven Shallcross, Chief Executive Officer and Chief Financial Officer of Synthetic Biologics is scheduled to present on Tuesday February 15, 2022 at 11:00 AM Eastern Time. Management will also be available to participate in 1×1 meetings with qualified investors throughout the conference. Synthetic’s presentation will be made available on their website at https://ir.syntheticbiologics.com/.

About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE American: SYN) is diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company recently announced it has entered into a definitive agreement to acquire VCN Biosciences, S.L. (VCN), which is developing a new oncolytic adenovirus (OV) platform designed for intravenous (IV) delivery to trigger tumor cell death and promote immune cell infiltration into tumors. The transaction is expected to close during the first quarter of 2022, and is subject to, among other things, the approval by the Spanish government of the Company’s acquisition of VCN under Spain’s Foreign Investment Act and other customary closing conditions. In addition, the Company’s lead candidates are: (1) SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous (IV) beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent (a) microbiome damage, (b) Clostridioides difficile infection (CDI), (c) overgrowth of pathogenic organisms, (d) the emergence of antimicrobial resistance (AMR), and (e) acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients, and (2) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases. For more information, please visit Synthetic Biologics’ website at www.syntheticbiologics.com.

SOURCE Synthetic Biologics, Inc.

Related

Filed Under: events

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

RSS Domain Market

  • .COM is the biggest franchise the world has ever known!
  • ebyte.org, domain name for sale
  • OPINR.com, domain name for sale
  • #wallet: HashtagWallet.com, domain name for sale
  • Knowledge Engineering: KnowledgeEngineering.com, domain name for sale
  • CryptoEncryption.org, domain name for sale
  • Bootstrapping.org, domain name for sale
  • Salade.org, domain name for sale
  • Cruise Market: CruiseMarket.org, domain name for sale
  • moveable.org, domain name for sale

Featured Posts

  • Volcano Summit ON LINE which will take place on Saturday June 13th 2020
  • Upcoming Events, June 5-12 2019
  • Derivatives & Hedging Foundations for Accountants, October 26-29, 2021
  • 2018 Wells Fargo Tech Summit, December 4, 2018, Stein Eriksen Lodge, Park City, Utah
  • The 2nd Annual Biopesticide Summit & Awards 2020, 19-20 May 2020, National Exhibition Centre, Birmingham, United Kingdom
  • The 7th Annual Winternational Embassy Showcase: Over 4,000 Participating Guests, More than 50 Embassies Were Represented, Showcasing Their Culture and Traditions at the Reagan Building
  • Zehnder’s Snowfest Offers World Class Snow & Ice Sculpting Competition and a Winter Wonderland of Family Fun January 23 – 28, 2019
  • Nobel Week opens with a press conference at the Royal Swedish Academy of Sciences On 7 December, 2019
  • Digital Transformation Middle East 2019, January 21-22, 2019, The Grosvenor House in Dubai, UAE
  • Market Research Media Will Participate in Investor Conferences

Media Partners

  • Technology Conferences
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Event Market
  • S3H

Copyright © 2018 ESN.net

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT